Lysosomal cysteine proteases (cathepsins): promising drug targets
- PMID: 12554931
- DOI: 10.1107/s0907444902021479
Lysosomal cysteine proteases (cathepsins): promising drug targets
Abstract
Papain-like lysosomal cysteine proteases are processive and digestive enzymes expressed in organisms from bacteria to humans. Their ubiquity alone makes them potential drug targets, with the assumption that appropriate specificities may be achieved. These enzymes have rather short active-site clefts, comprising three well defined substrate-binding subsites (S2, S1 and S1') and additionally have comparatively broad binding areas (S4, S3, S2', S3'). This geometry distinguishes them from other protease classes, such as serine and aspartic proteases, with six and eight substrate-binding sites, respectively. Exopeptidases (cathepsins B, C, H and X), in contrast to endopeptidases (such as cathepsins L, S, V and F), possess structural features that facilitate binding of N- and C-terminal groups of substrates in the active-site cleft. Other than a clear preference for free chain termini in the case of exopeptidases, the substrate-binding sites exhibit no strict specificities. Instead, their subsite preferences arise more from specific exclusions of substrate type. This presents a challenge for the design of inhibitors to target a specific cathepsin: only the cumulative effect of an assembly of inhibitor fragments can produce the desired result. The small number of papain-like lysosomal cysteine proteases (11 human enzymes are known) and the small number of substrate-binding sites calls for a innovative and empirical approach.
Similar articles
-
Papain-like lysosomal cysteine proteases and their inhibitors: drug discovery targets?Biochem Soc Symp. 2003;(70):15-30. doi: 10.1042/bss0700015. Biochem Soc Symp. 2003. PMID: 14587279 Review.
-
Crystal structure of human cathepsin S.Protein Sci. 1998 Jun;7(6):1294-302. doi: 10.1002/pro.5560070604. Protein Sci. 1998. PMID: 9655332 Free PMC article.
-
Cathepsins X and B can be differentiated through their respective mono- and dipeptidyl carboxypeptidase activities.Biochemistry. 2001 Mar 6;40(9):2702-11. doi: 10.1021/bi002460a. Biochemistry. 2001. PMID: 11258881
-
Comparative study on specificities of rat cathepsin L and papain: amino acid differences at substrate-binding sites are involved in their specificities.J Biochem. 1990 Dec;108(6):976-82. doi: 10.1093/oxfordjournals.jbchem.a123324. J Biochem. 1990. PMID: 2089043
-
Cysteine cathepsins: from structure, function and regulation to new frontiers.Biochim Biophys Acta. 2012 Jan;1824(1):68-88. doi: 10.1016/j.bbapap.2011.10.002. Epub 2011 Oct 12. Biochim Biophys Acta. 2012. PMID: 22024571 Free PMC article. Review.
Cited by
-
Probing cathepsin K activity with a selective substrate spanning its active site.Biochem J. 2003 Oct 15;375(Pt 2):307-12. doi: 10.1042/BJ20030468. Biochem J. 2003. PMID: 12837132 Free PMC article.
-
Redox-based inactivation of cysteine cathepsins by compounds containing the 4-aminophenol moiety.PLoS One. 2011;6(11):e27197. doi: 10.1371/journal.pone.0027197. Epub 2011 Nov 4. PLoS One. 2011. PMID: 22073285 Free PMC article.
-
Crystal structure of MOA in complex with a peptide fragment: A protease caught in flagranti.Curr Res Struct Biol. 2020 Apr 22;2:56-67. doi: 10.1016/j.crstbi.2020.04.003. eCollection 2020. Curr Res Struct Biol. 2020. PMID: 34235469 Free PMC article.
-
Residues in the hendra virus fusion protein transmembrane domain are critical for endocytic recycling.J Virol. 2012 Mar;86(6):3014-26. doi: 10.1128/JVI.05826-11. Epub 2012 Jan 11. J Virol. 2012. PMID: 22238299 Free PMC article.
-
Toxoplasma gondii cathepsin L is the primary target of the invasion-inhibitory compound morpholinurea-leucyl-homophenyl-vinyl sulfone phenyl.J Biol Chem. 2009 Sep 25;284(39):26839-50. doi: 10.1074/jbc.M109.003780. Epub 2009 Jul 13. J Biol Chem. 2009. PMID: 19596863 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
